Maybe AZN is going after ANCHOR market anyway? If Crestor is so great, perhaps it can dampen the LDL raising effects of Epanova? Grabbing part of a market share is better than having none, eh? Same way ARNA/VVUS/OREX are all competing in the weight loss arena?
Market Data 
Markets 
